Chen Qiyu, chairman of Fosun Pharmaceutical and Shanghai Henlius Biotech, did suggest the company may seek a listing on the new tech board in the future. Photo: Jonathan Wong Chen Qiyu, chairman of Fosun Pharmaceutical and Shanghai Henlius Biotech, did suggest the company may seek a listing on the new tech board in the future. Photo: Jonathan Wong
Chen Qiyu, chairman of Fosun Pharmaceutical and Shanghai Henlius Biotech, did suggest the company may seek a listing on the new tech board in the future. Photo: Jonathan Wong
Fosun Group

Fosun biotech unit Henlius has no plans for Shanghai tech board listing and is focused on Hong Kong IPO

  • Hong Kong flotation is our priority, CEO says

Topic |   Fosun Group
Chen Qiyu, chairman of Fosun Pharmaceutical and Shanghai Henlius Biotech, did suggest the company may seek a listing on the new tech board in the future. Photo: Jonathan Wong Chen Qiyu, chairman of Fosun Pharmaceutical and Shanghai Henlius Biotech, did suggest the company may seek a listing on the new tech board in the future. Photo: Jonathan Wong
Chen Qiyu, chairman of Fosun Pharmaceutical and Shanghai Henlius Biotech, did suggest the company may seek a listing on the new tech board in the future. Photo: Jonathan Wong
READ FULL ARTICLE